Related Experiment Video
Updated: Mar 22, 2026
03:47
A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
749
[The treatment of tuberculosis]
Thomas Degen1, Thomas Bregenzer2
11 Klinik für Geriatrie, Universitätsspital Zürich.
Praxis
|April 15, 2016
Summary
Tuberculosis incidence is declining, but treatment questions arise, especially with suspected antimicrobial resistance. Standard treatment involves a four-drug regimen, with adherence and duration critical for cure.
Area of Science:
- Microbiology
- Infectious Diseases
- Public Health
Context:
- While tuberculosis incidence declines, clinical challenges persist, particularly in contact tracing and diagnosing antimicrobial resistance.
- Standard empiric treatment involves a four-drug regimen (rifampin, isoniazid, ethambutol, pyrazinamide) for active disease.
- Latent tuberculosis treatment typically uses a 6-9 month isoniazid regimen.
Purpose:
- To outline current tuberculosis treatment strategies, emphasizing the importance of adherence and duration for successful eradication.
- To highlight considerations for complex cases, including immunocompromised patients and suspected drug resistance.
Summary:
- The initial phase of tuberculosis treatment aims to reduce bacterial load, followed by consolidation therapy to eliminate remaining pathogens.
- Adherence to prescribed treatment duration and regimens is paramount for achieving a cure.
- Specialized centers are recommended for complex tuberculosis cases, such as those in immunocompromised individuals or with suspected resistance.
Impact:
- Ensuring effective tuberculosis treatment and control through adherence to established guidelines.
- Facilitating appropriate management of complex and drug-resistant tuberculosis cases.
- Contributing to the global effort to reduce tuberculosis morbidity and mortality.
Keywords:
DOTResistenzTherapieadhärenzadherenceadhérence au traitementantituberculous treatmentantituberkulöse Therapieresistancerésistancetraitement antituberculeuxMore Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
19.4K
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
2.4K
Related Concept Videos
01:28Pulmonary Tuberculosis V
750
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
750
01:26Pulmonary Tuberculosis IV
626
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
626
01:29Pulmonary Tuberculosis I
1.2K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
01:31Pulmonary Tuberculosis III
1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.3K
01:28Pulmonary Tuberculosis II
1.9K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.9K
01:28Pneumonia IV: Management
1.0K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.0K